Verrica Pharmaceuticals Inc(NASDAQ:VRCA) 
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; which has completed phase II clinical trial fo...
Website: http://www.verrica.com
Founded: 2013
Full Time Employees: 17
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.10
H 5.40
L 4.00
C 5.30
V 786,282
10EMA 5.30
20EMA 5.30
60EMA 5.30
120EMA 5.30
250EMA 5.30